QR Code

B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies

Background: Patients with primary antibody deficiencies are at risk in the current COVID-19 pandemic due to their impaired response to infection and vaccination. Specifically, patients with common variable immunodeficiency (CVID) generated poor spike-specific antibody and T cell responses after immu...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Federica Pulvirenti, Ane Fernandez Salinas, Cinzia Milito, Sara Terreri, Eva Piano Mortari, Concetta Quintarelli, Stefano Di Cecca, Gianluca Lagnese, Alessandra Punziano, Marika Guercio, Livia Bonanni, Stefania Auria, Francesca Villani, Christian Albano, Franco Locatelli, Giuseppe Spadaro, Rita Carsetti, Isabella Quinti
Hōputu: Artigo
Reo:Inglês
I whakaputaina: MDPI AG 2021-10-01
Rangatū:Cells
Ngā marau:
common variable immunodeficiencies
SARS-CoV-2
COVID-1
BNT162b2
vaccine
third dose
Urunga tuihono:https://www.mdpi.com/2073-4409/10/11/2915
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite